REVIEW: tau protein pathology in Alzheimer's disease and related disorders.
about
Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filamentsAutoproteolytic fragments are intermediates in the oligomerization/aggregation of the Parkinson's disease protein alpha-synuclein as revealed by ion mobility mass spectrometryThe Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's DiseaseArgyrophilic grain diseaseRegulation of microtubule dynamics and myogenic differentiation by MURF, a striated muscle RING-finger proteinI1PP2A affects tau phosphorylation via association with the catalytic subunit of protein phosphatase 2AThe excitotoxin quinolinic acid induces tau phosphorylation in human neuronsPericellular innervation of neurons expressing abnormally hyperphosphorylated tau in the hippocampal formation of Alzheimer's disease patients.Tau pathology generated by overexpression of tau.Alpha7 nicotinic acetylcholine receptor: a link between inflammation and neurodegeneration.The pathogenesis of multiple system atrophy: past, present, and future.Focal expression of mutated tau in entorhinal cortex neurons of rats impairs spatial working memory.Aminopeptidases do not directly degrade tau protein.Frequent and symmetric deposition of misfolded tau oligomers within presynaptic and postsynaptic terminals in Alzheimer's disease.Neurofibrillary tangles and the deposition of a beta amyloid peptide with a novel N-terminal epitope in the brains of wild Tsushima leopard catsLead dysregulates serine/threonine protein phosphatases in human neurons.Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic miceProteomics in neurodegenerative diseases: Methods for obtaining a closer look at the neuronal proteome.Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degenerationFilamentous tau in oligodendrocytes and astrocytes of transgenic mice expressing the human tau isoform with the P301L mutation.Biochemical analysis of tau proteins in argyrophilic grain disease, Alzheimer's disease, and Pick's disease : a comparative studymiR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo.Frontotemporal lobar degeneration: current concepts in the light of recent advances.Pharmacotherapeutic targets in Alzheimer's diseaseMetal ions, Alzheimer's disease and chelation therapy.Neuropathology of multiple system atrophy: new thoughts about pathogenesis.Chemical Methods to Knock Down the Amyloid Proteins.Pre-aggregated Aβ1-42 peptide increases tau aggregation and hyperphosphorylation after short-term application.Conformational sampling with implicit solvent models: application to the PHF6 peptide in tau protein.Towards a Better Understanding of GABAergic Remodeling in Alzheimer's Disease.Expression of Tau Pathology-Related Proteins in Different Brain Regions: A Molecular Basis of Tau Pathogenesis.Oligodendroglial tau filament formation in transgenic mice expressing G272V tau.Development of an assay to screen for inhibitors of tau phosphorylation by cdk5.Consensus models for CDK5 inhibitors in silico and their application to inhibitor discovery.ReMAPping the microtubule landscape: How phosphorylation dictates the activities of microtubule-associated proteins.The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease.Effect of Continuous Propofol Infusion in Rat on Tau Phosphorylation with or without Temperature Control.Pick-and-Place Assembly of Single Microtubules.The cellular and molecular pathology of the motor system in hereditary spastic paraparesis due to mutation of the spastin gene.
P2860
Q24599152-80564F58-334A-477A-8B43-7F14FB93FF62Q24632795-EB3F9A4E-F0E6-4676-8BF6-A6F613E9A934Q28254943-8F8B64E3-4669-4240-B2A1-82531F1417C2Q28266563-179C5C89-46C1-43DA-9ABB-5ADF5714230AQ28513866-F5386297-5F95-4777-A26C-ADF85017A7D0Q28566668-7A08E2AA-F3AC-46AE-B14B-1804CEAC8446Q33485236-D04DC101-9A17-4A59-BE08-D989FDB04FA2Q33633043-779343C0-1C38-48E8-8DDE-53E5084CD4BFQ33793293-E1D9AE2B-A470-432A-B913-712FFBBEC60AQ33955075-AE56364A-C4FB-4D96-93D2-BC045E477E4FQ34048136-2C9368E3-7034-4F21-A995-FA9E41AF3F99Q34288430-4DAADD6B-2168-41EC-85CD-8D5D633401CCQ34335712-898A142B-506F-4D0E-856D-ECB05B58F877Q34402143-FE964BE7-CB9C-4D58-A9C1-734AF9B39BA7Q34441477-0BA719B8-3159-4CF1-BE05-975C21568415Q34500924-DFA617C2-AA0E-4456-AA02-400840F0F8A2Q34556945-19D95078-FE5F-4603-B731-A2EB1B420D87Q34687145-754A0B68-72A8-4B18-A440-D9A70B8232A4Q35241298-1EF7F122-50E7-47D3-9400-CF5349EE288CQ35327851-40EC61E3-6CAF-43CD-97DB-9A07C83440C8Q35748867-702D89E6-9254-4FD5-BFA2-806919C83E55Q35789255-8CBBAD60-C04E-4CD4-8F34-020E74213963Q36251998-698A6CCB-89BB-4714-87CF-73B6F7E33C54Q36817228-5D8A3F0F-0A22-4893-9974-AFB975130201Q37295067-465D230F-5F48-4925-A5EE-DFC9419A7781Q37853261-1136AF21-C843-4034-945E-38DF523FCDF2Q38258246-B8476E51-43B7-4092-B240-CCE954561E0DQ38740479-49C94A39-3D71-4F61-9FDB-CF7AD772C22CQ39626472-B935A296-C547-4BC1-8637-9C3A057536EFQ41047006-4467D548-5980-4126-92E6-4CE5184B06F7Q41574564-C082E282-CBD2-441A-BC85-1EEACCA86D3CQ42288828-EE8D7FD7-547C-48FF-9C58-E0D7D06A0782Q43650971-423401A6-8F85-48D2-8CD5-6EF11658D3F3Q44789917-226F9D1C-7CD4-4C01-9A0D-D4B78244B261Q45955634-BB137DA8-CECB-4F7E-A3F5-F18C1D1D407DQ46180253-43A60603-5995-4AB4-B97F-C16A27173E72Q46593984-0C106CD7-3738-492D-AD52-9B60EDCE559FQ47595540-3212D65F-04A0-4C02-9797-1DCDF999E7F0Q47941659-E2FDFE32-4364-4454-8E55-1B7CDF9EF8DBQ48125857-430EB72F-4F2F-4FFA-80BF-3264C4AA0500
P2860
REVIEW: tau protein pathology in Alzheimer's disease and related disorders.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
REVIEW: tau protein pathology in Alzheimer's disease and related disorders.
@ast
REVIEW: tau protein pathology in Alzheimer's disease and related disorders.
@en
type
label
REVIEW: tau protein pathology in Alzheimer's disease and related disorders.
@ast
REVIEW: tau protein pathology in Alzheimer's disease and related disorders.
@en
prefLabel
REVIEW: tau protein pathology in Alzheimer's disease and related disorders.
@ast
REVIEW: tau protein pathology in Alzheimer's disease and related disorders.
@en
P2860
P1476
REVIEW: tau protein pathology in Alzheimer's disease and related disorders.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2990.1999.00182.X
P577
1999-06-01T00:00:00Z